Julia Aulin
Researcher at Department of Medical Sciences; Cardiology
- E-mail:
- julia.aulin@medsci.uu.se
- Visiting address:
- Akademiska sjukhuset, ingång 40, 5 tr
751 85 UPPSALA - Postal address:
- Akademiska sjukhuset, ingång 40, 5 tr
751 85 UPPSALA
Download contact information for Julia Aulin at Department of Medical Sciences; Cardiology
Postdoctoral position at Department of Medical Sciences; Translational Neurology
- Visiting address:
- Akademiska Sjukhuset, Ing 85 3 tr
751 85 Uppsala - Postal address:
- Box 593
75124 UPPSALA
Researcher at UCR-Uppsala Clinical Research center
- E-mail:
- julia.aulin@ucr.uu.se
- Visiting address:
- Dag Hammarskjölds väg 38
- Postal address:
- Uppsala Science Park
Dag Hammarskjölds väg 38
751 85 UPPSALA
Download contact information for Julia Aulin at UCR-Uppsala Clinical Research center
Short presentation
MD, PhD.
Publications
Selection of publications
Part of American Heart Journal, p. 13-24, 2022
- DOI for Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model
- Download full text (pdf) of Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model
Serum Neurofilament Light Chain in Patients With Atrial Fibrillation
Part of Journal of the American Heart Association, 2022
- DOI for Serum Neurofilament Light Chain in Patients With Atrial Fibrillation
- Download full text (pdf) of Serum Neurofilament Light Chain in Patients With Atrial Fibrillation
Biomarkers of inflammation in atrial fibrillation
2021
Part of Journal of Thrombosis and Haemostasis, p. 2287-2295, 2020
- DOI for Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE-LY trials.
- Download full text (pdf) of Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE-LY trials.
Part of Open heart, 2018
- DOI for Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial
- Download full text (pdf) of Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial
Part of Heart, p. 508-517, 2016
Part of American Heart Journal, p. 1151-1160, 2015
Recent publications
Part of Journal of the American Heart Association, 2025
- DOI for Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation Not Receiving Oral Anticoagulation
- Download full text (pdf) of Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation Not Receiving Oral Anticoagulation
Neurofilament Light Chain and Risk of Stroke in Patients With Atrial Fibrillation
Part of Circulation, p. 1090-1100, 2024
Part of American Heart Journal, p. 13-24, 2022
- DOI for Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model
- Download full text (pdf) of Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model
Serum Neurofilament Light Chain in Patients With Atrial Fibrillation
Part of Journal of the American Heart Association, 2022
- DOI for Serum Neurofilament Light Chain in Patients With Atrial Fibrillation
- Download full text (pdf) of Serum Neurofilament Light Chain in Patients With Atrial Fibrillation
Biomarkers of inflammation in atrial fibrillation
2021
All publications
Articles in journal
Part of Journal of the American Heart Association, 2025
- DOI for Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation Not Receiving Oral Anticoagulation
- Download full text (pdf) of Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation Not Receiving Oral Anticoagulation
Neurofilament Light Chain and Risk of Stroke in Patients With Atrial Fibrillation
Part of Circulation, p. 1090-1100, 2024
Part of American Heart Journal, p. 13-24, 2022
- DOI for Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model
- Download full text (pdf) of Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model
Serum Neurofilament Light Chain in Patients With Atrial Fibrillation
Part of Journal of the American Heart Association, 2022
- DOI for Serum Neurofilament Light Chain in Patients With Atrial Fibrillation
- Download full text (pdf) of Serum Neurofilament Light Chain in Patients With Atrial Fibrillation
Part of Journal of Thrombosis and Haemostasis, p. 2287-2295, 2020
- DOI for Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE-LY trials.
- Download full text (pdf) of Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE-LY trials.
Part of Open heart, 2018
- DOI for Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial
- Download full text (pdf) of Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial
Part of Heart, p. 508-517, 2016
Part of American Heart Journal, p. 1151-1160, 2015
Part of European Heart Journal, p. 1115-1116, 2014